Cambridge Investment Research Advisors
CNSY

Cambridge Investment Research Advisors’s Cerenome CNSY Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CNSY Stock Details CNSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-538
Closed -$2K – 4155
2026
Q1 		$2K Hold
538
– – ﹤0.01% 3918
2025
Q4 		$7K Buy
538
+118
+28% +$1.78K ﹤0.01% 3806
2025
Q3 		$7K Buy
+420
New +$5.16K ﹤0.01% 3709
2019
Q3 		– Sell
-1
Closed -$5K – 2393
2019
Q2 		$5K Hold
1
– – ﹤0.01% 2193
2019
Q1 		$5K Buy
+1
New +$5.28K ﹤0.01% 2271

Other funds holding CNSY

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cambridge Investment Research Advisors's CNSY Position: Q2 2026 in Review

Cambridge Investment Research Advisors sold out of Cerenome (CNSY) in Q2 2026, closing a stake of 538 shares — an estimated $2K sold.

Cambridge Investment Research Advisors first reported a position in CNSY in Q1 2019 and held it in 5 quarters. The position peaked at $7K in Q4 2025. 21 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

  • Cambridge Investment Research Advisors reported no remaining Cerenome position as of Q2 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 538 Cerenome shares in Q2 2026, an estimated $2K.
  • Cambridge Investment Research Advisors first reported a position in Cerenome in Q1 2019 and held it in 5 quarters.
  • Cambridge Investment Research Advisors's Cerenome position peaked at $7K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Cerenome as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.